RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
Updated: 12 hours 43 min ago
Thu, 03/21/2024 - 02:00
Merck’s Keytruda Continues NSCLC Losing Streak with Phase III Flop 3/21/2024
Thu, 03/21/2024 - 02:00
Mirador Launches with $400M in Funding, Targets Precision Medicines 3/21/2024
Thu, 03/21/2024 - 02:00
Medicare Likely to Negotiate Prices for Obesity Drugs in Next Few Years: CBO 3/21/2024
Thu, 03/21/2024 - 02:00
Money Talk: Salary Trends and Raises 3/21/2024
Thu, 03/21/2024 - 02:00
Bayer Eliminates Nearly Half of Its Executive Positions in Major Overhaul 3/21/2024
Thu, 03/21/2024 - 02:00
Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug 3/21/2024
Thu, 03/21/2024 - 02:00
Capstan Secures $175M Oversubscribed Series B with Backing from J&J, Bayer and BMS 3/21/2024
Thu, 03/21/2024 - 02:00
New Graduates Struggle in Current Biopharma Job Market 3/21/2024
Thu, 03/21/2024 - 02:00
Top 5 Remote Quality-Control Jobs 3/21/2024
Wed, 03/20/2024 - 02:00
Orchard Sets $4.25M US Price for Gene Therapy Lenmeldy on Heels of Approval 3/20/2024
Wed, 03/20/2024 - 02:00
BMS Racks Up Phase III Win in Liver Cancer Targeted by AstraZeneca and Roche 3/20/2024
Wed, 03/20/2024 - 02:00
Lonza to Buy Roche Biologics Manufacturing Site in California for $1.2B 3/20/2024
Wed, 03/20/2024 - 02:00
Clasp Emerges with $150M Series A Financing to Advance T Cell Engagers 3/20/2024
Wed, 03/20/2024 - 02:00
Historic Approval for MASH, CAR-Ts in the Spotlight 3/20/2024
Wed, 03/20/2024 - 02:00
What Another Trump Presidency Could Mean for Big Pharma 3/20/2024
Wed, 03/20/2024 - 02:00
Takeda Reaps Rewards of $5.2B Ariad Bet as FDA Expands Iclusig’s Label 3/20/2024
Wed, 03/20/2024 - 02:00
How to Talk About Politics at Work 3/20/2024
Wed, 03/20/2024 - 02:00
Novo Invests $556M in China Operations to Boost Manufacturing Capacity 3/20/2024
Wed, 03/20/2024 - 02:00
Italfarmaco Touts Positive Results in Phase III DMD Trial Ahead of PDUFA 3/20/2024
Wed, 03/20/2024 - 02:00
EU Parliament Endorses New Pharma Legislation, Provides More Market Protection for Companies 3/20/2024